Entyvio

Background

Treatment of ulcerative colitis and Crohn’s disease

Approved applications

Entyvio was approved by the U.S. Food & Drug Administration (FDA) in 2014 and is available in more than 60 countries worldwide.

Therapeutic Area

Ulcerative Colitis
Crohn's Disease

Acquisition Date

Mar 2020

Marketer

Seller